Lindbrook Capital, LLC Grifols Sa Transaction History

Lindbrook Capital, LLC

$1.06 Billion
Q1 2025

A detailed history of Lindbrook Capital, LLC transactions in Grifols Sa stock. As of the latest transaction made, Lindbrook Capital, LLC holds 1,926 shares of GRFS stock, worth $16,775. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,926

Previous 1,805 6.7%

Holding current value

$16,775

Previous $13,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 05, 2025	BUY	$6.62 - $8.71 $801 - $1,053	121 Added 6.7%	1,926 $13,000
Q4 2024 Feb 06, 2025	SELL	$6.99 - $9.55 $789 - $1,079	-113 Reduced 5.89%	1,805 $13,000
Q3 2024 Nov 01, 2024	BUY	$6.28 - $9.38 $37 - $56	6 Added 0.31%	1,918 $17,000
Q2 2024 Jul 31, 2024	BUY	$6.27 - $7.7 $2,000 - $2,456	319 Added 20.03%	1,912 $12,000
Q1 2024 Apr 25, 2024	SELL	$5.47 - $11.38 $1,208 - $2,514	-221 Reduced 12.18%	1,593 $10,000

Q4 2023 Jan 31, 2024	BUY	$7.71 - $11.56 $6,653 - $9,976	863 Added 90.75%	1,814 $20,000
Q3 2023 Oct 25, 2023	BUY	$8.91 - $10.91 $187 - $229	21 Added 2.26%	951 $8,000
Q2 2023 Jul 28, 2023	SELL	$7.14 - $9.29 $1,349 - $1,755	-189 Reduced 16.89%	930 $8,000
Q1 2023 Apr 26, 2023	SELL	$6.65 - $10.69 $4,901 - $7,878	-737 Reduced 39.71%	1,119 $8,000
Q4 2022 Jan 24, 2023	SELL	$5.96 - $8.53 $6,818 - $9,758	-1,144 Reduced 38.13%	1,856 $0
Q3 2022 Nov 10, 2022	SELL	$5.95 - $14.3 $14,190 - $34,105	-2,385 Reduced 44.29%	3,000 $18,000
Q2 2022 Aug 01, 2022	BUY	$10.6 - $13.28 $2,618 - $3,280	247 Added 4.81%	5,385 $64,000
Q1 2022 Apr 21, 2022	SELL	$10.37 - $12.73 $7,756 - $9,522	-748 Reduced 12.71%	5,138 $60,000
Q4 2021 Jan 18, 2022	BUY	$10.21 - $15.27 $52,162 - $78,014	5,109 Added 657.53%	5,886 $66,000
Q3 2021 Nov 05, 2021	BUY	$14.07 - $17.3 $1,294 - $1,591	92 Added 13.43%	777 $11,000
Q1 2021 Apr 28, 2021	SELL	$15.15 - $19.78 $1,848 - $2,413	-122 Reduced 15.12%	685 $12,000
Q4 2020 Jan 27, 2021	SELL	$16.86 - $19.67 $961 - $1,121	-57 Reduced 6.6%	807 $15,000
Q3 2020 Nov 03, 2020	BUY	$15.4 - $20.16 $3,696 - $4,838	240 Added 38.46%	864 $15,000
Q2 2020 Jul 27, 2020	BUY	$18.24 - $21.45 $1,568 - $1,844	86 Added 15.99%	624 $11,000
Q1 2020 Apr 22, 2020	SELL	$16.28 - $25.63 $13,447 - $21,170	-826 Reduced 60.56%	538 $11,000
Q3 2019 Oct 31, 2019	BUY	$19.85 - $22.76 $8,098 - $9,286	408 Added 42.68%	1,364 $27,000
Q2 2019 Jul 24, 2019	BUY	$17.59 - $21.1 $3,394 - $4,072	193 Added 25.29%	956 $20,000
Q1 2019 Apr 23, 2019	SELL	$18.01 - $20.11 $3,223 - $3,599	-179 Reduced 19.0%	763 $15,000
Q4 2018 Feb 07, 2019	BUY	$17.44 - $21.53 $16,428 - $20,281	942 New	942 $17,000

Others Institutions Holding GRFS

# of Institutions

200

Shares Held

148M

Call Options Held

76.1K

Put Options Held

58.2K

View Full List

About Grifols SA

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.91B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

More about GRFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Grifols Sa Transaction History